Moleculin Biotech, Inc. (MBRX)

NASDAQ: MBRX · IEX Real-Time Price · USD

4.315

-0.155 (-3.47%)

At close: Jul 19, 2024, 4:00 PM

4.310

-0.005 (-0.12%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Moleculin Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Selling, General & Admin	9.77	10.02	11.54	8.39	6.79	6.31	Upgrade
Research & Development	18.05	19.49	18.97	14.42	12.76	11.01	Upgrade
Other Operating Expenses	0.13	0.13	0.13	0.16	0.2	0.2	Upgrade
Operating Expenses	27.95	29.63	30.64	22.97	19.74	17.52	Upgrade
Operating Income	-27.95	-29.63	-30.64	-22.97	-19.74	-17.52	Upgrade
Other Expense / Income	-1.13	0.14	-1.62	-7.07	-2.39	-4.09	Upgrade
Pretax Income	-26.82	-29.77	-29.03	-15.89	-17.36	-13.43	Upgrade
Income Tax	0	0	0	0	0	-0.23	Upgrade
Net Income	-26.82	-29.77	-29.03	-15.89	-17.36	-13.21	Upgrade
Shares Outstanding (Basic)	2	2	2	2	1	0	Upgrade
Shares Outstanding (Diluted)	2	2	2	2	1	0	Upgrade
Shares Change	28.67%	3.60%	6.43%	172.97%	45.07%	57.20%	Upgrade
EPS (Basic)	-13.04	-15.07	-15.22	-8.85	-26.40	-29.25	Upgrade
EPS (Diluted)	-13.04	-15.07	-15.22	-8.85	-26.40	-29.25	Upgrade
Free Cash Flow	-24.93	-24.23	-27.71	-18.97	-18.15	-17.25	Upgrade
Free Cash Flow Per Share	-10.11	-12.26	-14.53	-10.59	-27.64	-38.12	Upgrade
EBITDA	-26.7	-29.64	-28.9	-15.73	-17.16	-13.24	Upgrade
Depreciation & Amortization	0.13	0.13	0.13	0.16	0.2	0.2	Upgrade
EBIT	-26.82	-29.77	-29.03	-15.89	-17.36	-13.43	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).